enterologics, inc

Enterologics, Inc. (OTCBB: ELGO.OB) Unveils Novel Business Strategy to Develop Live Biotherapeutics for Gastrointestinal Diseases

Enterologics, Inc., a biotechnology company, is dedicated to the development of live biotherapeutic products for gastrointestinal (GI) disorders, that it believes are poorly addressed by current therapies. Key examples include pouchitis, irritable bowel syndrome (IBS), Crohn’s disease,... - April 15, 2011